0001209191-22-010239.txt : 20220216 0001209191-22-010239.hdr.sgml : 20220216 20220216172219 ACCESSION NUMBER: 0001209191-22-010239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220214 FILED AS OF DATE: 20220216 DATE AS OF CHANGE: 20220216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richardson Charles E CENTRAL INDEX KEY: 0001875096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40655 FILM NUMBER: 22644707 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 208 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Icosavax, Inc. CENTRAL INDEX KEY: 0001786255 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVE E, SUITE 208 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 737-0085 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVE E, SUITE 208 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-14 0 0001786255 Icosavax, Inc. ICVX 0001875096 Richardson Charles E C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208 SEATTLE WA 98102-3793 0 1 0 0 SVP, Technical Operations Common Stock 2022-02-14 4 M 0 66375 0.84 A 161200 D Common Stock 2022-02-14 4 M 0 6186 1.04 A 167386 D Stock Option (Right to Buy) 0.84 2022-02-14 4 M 0 66375 0.00 D 2029-09-12 Common Stock 66375 43489 D Stock Option (Right to Buy) 1.04 2022-02-14 4 M 0 6186 0.00 D 2031-01-28 Common Stock 6186 16657 D 25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter. 25% of the shares subject to the option vested on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter. s/ Elizabeth Bekiroglu, Attorney-in-Fact for Charles E. Richardson 2022-02-16